Tyrosine kinase inhibitor
Selected Variant
HY-10421-01
Size: 5 mg
Tyrosine kinase inhibitor is a potent tyrosine kinase inhibitor.
Product Specifications
CAS Number
1021950-26-4
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Tyrosine-kinase-inhibitor.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : ≥ 46 mg/mL
Smiles
O=C(NC1=CC=C(C=C1)F)C2(CC2)C(NC3=CC=C(C=C3)OC4=C5C(NC(C(NCCN6CCOCC6)=O)=C5)=NC=C4)=O
Molecular Formula
C31H31FN6O5
Molecular Weight
586.61
References & Citations
[1]Inoue T, et al. 
 Two cases of gastrointestinal perforation after radiotherapy in patients receiving tyrosine kinase inhibitor for advanced renal cell carcinoma.
 World J Surg Oncol. 2012 Aug 20;10 (1) :167.|[2]Bowen JM, et al. 
 Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea.
 Cancer Biol Ther. 2012 Nov 1;13 (13) .|[3]Sun FK, et al. 
 Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma.
 Chin Med J (Engl) . 2012 Jun;125 (12) :2231-4.|[4]Thamm DH.
 Tyrosine kinase inhibitor special issue.
 Vet Comp Oncol. 2012 Sep;10 (3) :161-2. doi: 10.1111/j.1476-5829.2012.00339.x.|[5]Eriksson A, et al. 
 The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia.
 Blood Cancer J. 2012 Aug 3;2:e81. doi: 10.1038/bcj.2012.28.|[6]Paul MK, et al. Tyrosine kinase - Role and significance in Cancer. Int J Med Sci. 2004;1 (2) :101-115.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog